Mesenchymal Stem Progeitors are derived from human embryonic cell line, H9 (WA09). Cells are >80% CD90, CD105, CD166 and CD73 positive and <5% Oct4 positive. Cells have the capabilties to:
Form adherent monolayers – ideal for 96-and 384-well formats for high throughput and high content cell-based assays.
To differentiate into a wide variety of mesenchymal subtypes, including osteogenic and chondrogenic lineages (but not adipogenic)– ideal for drug discovery for a wide variety of biological targets and basic research in bone, cartilage, metabolic and immunological diseases.
Passage up to 10X.
Note: Please include a 30 USD dry ice charge when ordering. Pricing is for US and Canada only.
Specifications:
Cell Type: mesenchymal progenitor cells Species: human Source: derived from human embryonic cell line, H9 (WA09) Morphology: fibroblastic
Quantity: >1×10^6 cells per vial (viable post-thaw) Shipping method: dry ice
Storage: liquid nitrogen
Growth Properties: adherent, proliferative Medium: αMEM Medium supplemented with 10% FBS, Pen/Strep and L-glutamine
Phenotyping: Cells are >80% CD90, CD105, CD166 and CD73 positive and <5% Oct4 positive. DNA fingerprint: Results are consistent with the presence of a single cell line with no evidence of culture cross contamination.
Pathogen testing: This lot was derived from the H9 hESC line that has been tested for Hepatitis B, Hepatitis C, HIV-1, HIV-2, HTLV-I/II, HSV1, HSV2, EBV, and CMV. The H9 cell line has been tested and shown to be negative (performed by GIVF Laboratories). Mesenchymal cells are also tested for sterility and mycoplasma contamination.
